• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨桥蛋白在体外介导矿化而非成骨细胞发育。

Osteopontin mediates mineralization and not osteogenic cell development in vitro.

作者信息

Holm Erik, Gleberzon Jared S, Liao Yinyin, Sørensen Esben S, Beier Frank, Hunter Graeme K, Goldberg Harvey A

机构信息

*Department of Biochemistry, Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario, Canada, N6A 5C1.

†Department of Molecular Biology and Genetics, Aarhus University, Gustav Wieds Vej 10, DK-8000 Aarhus, Denmark.

出版信息

Biochem J. 2014 Dec 15;464(3):355-64. doi: 10.1042/BJ20140702.

DOI:10.1042/BJ20140702
PMID:25310312
Abstract

Biomineralization is a complex process in the development of mineralized tissues such as bone and pathological calcifications such as atherosclerotic plaques, kidney stones and gout. Osteopontin (OPN), an anionic phosphoprotein, is expressed in mineralizing tissues and has previously been demonstrated to be a potent inhibitor of hydroxyapatite formation. The OPN-deficient (Opn-/-) mouse displays a hypermineralized bone phenotype starting at 12 weeks postnatally. By isolating and culturing Opn-/- and wild-type (WT) osteoblasts, we sought to determine the role of OPN and two of its functional peptides in osteoblast development and mineralization. Opn-/- osteoblasts had significantly increased mineral deposition relative to their WT counterparts, with no physiologically relevant change in gene expression of osteogenic markers. Supplementation with bovine milk OPN (mOPN) led to a dramatic reduction in mineral deposition by the Opn-/- osteoblasts. Treatment with OPN-derived peptides corresponding to phosphorylated OPN-(220-235) (P3) and non-phosphorylated OPN-(65-80) (OPAR) also rescued the hypermineralization phenotype of Opn-/- osteogenic cultures. Supplementation with mOPN or the OPN-derived peptides did not alter the expression of terminal osteogenic markers. These data suggest that OPN plays an important role in the regulation of biomineralization, but that OPN does not appear to affect osteoblast cell development in vitro.

摘要

生物矿化是矿化组织(如骨骼)发育以及病理性钙化(如动脉粥样硬化斑块、肾结石和痛风)过程中的一个复杂过程。骨桥蛋白(OPN)是一种阴离子磷蛋白,在矿化组织中表达,此前已被证明是羟基磷灰石形成的有效抑制剂。OPN基因缺陷(Opn-/-)小鼠在出生后12周开始表现出骨矿化过度的表型。通过分离和培养Opn-/-和野生型(WT)成骨细胞,我们试图确定OPN及其两个功能肽在成骨细胞发育和矿化中的作用。与野生型成骨细胞相比,Opn-/-成骨细胞的矿物质沉积显著增加,而成骨标志物的基因表达没有发生生理相关变化。补充牛乳OPN(mOPN)可导致Opn-/-成骨细胞的矿物质沉积显著减少。用与磷酸化OPN-(220-235)(P3)和非磷酸化OPN-(65-80)(OPAR)对应的OPN衍生肽处理也挽救了Opn-/-成骨培养物的矿化过度表型。补充mOPN或OPN衍生肽不会改变终末成骨标志物的表达。这些数据表明,OPN在生物矿化调节中起重要作用,但OPN似乎不影响体外成骨细胞的发育。

相似文献

1
Osteopontin mediates mineralization and not osteogenic cell development in vitro.骨桥蛋白在体外介导矿化而非成骨细胞发育。
Biochem J. 2014 Dec 15;464(3):355-64. doi: 10.1042/BJ20140702.
2
BMP9 prevents induction of osteopontin in JNK-inactivated osteoblasts via Hey1-Id4 interaction.BMP9 通过 Hey1-Id4 相互作用防止 JNK 失活的成骨细胞中骨桥蛋白的诱导。
Int J Biochem Cell Biol. 2019 Nov;116:105614. doi: 10.1016/j.biocel.2019.105614. Epub 2019 Sep 21.
3
JNK inactivation suppresses osteogenic differentiation, but robustly induces osteopontin expression in osteoblasts through the induction of inhibitor of DNA binding 4 (Id4).JNK 失活抑制成骨分化,但通过诱导 DNA 结合抑制因子 4(Id4),强烈诱导成骨细胞中骨桥蛋白的表达。
FASEB J. 2019 Jun;33(6):7331-7347. doi: 10.1096/fj.201802465R. Epub 2019 Mar 18.
4
Inositol hexakisphosphate inhibits mineralization of MC3T3-E1 osteoblast cultures.肌醇六磷酸抑制 MC3T3-E1 成骨细胞培养物的矿化。
Bone. 2010 Apr;46(4):1100-7. doi: 10.1016/j.bone.2010.01.367. Epub 2010 Jan 14.
5
Synergistic effect of extracellularly supplemented osteopontin and osteocalcin on stem cell proliferation, osteogenic differentiation, and angiogenic properties.骨桥蛋白和骨钙素对干细胞增殖、成骨分化和血管生成特性的协同作用。
J Cell Biochem. 2019 Apr;120(4):6555-6569. doi: 10.1002/jcb.27948. Epub 2018 Oct 25.
6
A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.一种新型胶原结合肽通过Ca2+/钙调蛋白依赖性蛋白激酶II/ERK/AP-1信号通路促进人骨髓间充质干细胞的成骨分化。
Cell Signal. 2008 Apr;20(4):613-24. doi: 10.1016/j.cellsig.2007.11.012. Epub 2007 Nov 29.
7
Expression of extracellular matrix proteins in human periodontal ligament cells during mineralization in vitro.体外矿化过程中人类牙周膜细胞外基质蛋白的表达
J Periodontol. 1997 Apr;68(4):320-7. doi: 10.1902/jop.1997.68.4.320.
8
Mineralization-inhibiting effects of transglutaminase-crosslinked polymeric osteopontin.转谷氨酰胺酶交联的聚骨桥蛋白的矿化抑制作用
Bone. 2017 Aug;101:37-48. doi: 10.1016/j.bone.2017.04.007. Epub 2017 Apr 18.
9
In vivo overexpression of tissue-nonspecific alkaline phosphatase increases skeletal mineralization and affects the phosphorylation status of osteopontin.组织非特异性碱性磷酸酶的体内过表达增加了骨骼矿化,并影响了骨桥蛋白的磷酸化状态。
J Bone Miner Res. 2013 Jul;28(7):1587-98. doi: 10.1002/jbmr.1901.
10
Human serine protease HTRA1 positively regulates osteogenesis of human bone marrow-derived mesenchymal stem cells and mineralization of differentiating bone-forming cells through the modulation of extracellular matrix protein.人丝氨酸蛋白酶 HTRA1 通过调节细胞外基质蛋白正向调控人骨髓间充质干细胞成骨及成骨分化细胞的矿化。
Stem Cells. 2012 Oct;30(10):2271-82. doi: 10.1002/stem.1190.

引用本文的文献

1
Deficiency of Human Mesenchymal Stem Cells: Impact on Osteogenic, Chondrogenic, and Adipogenic Differentiation.人骨髓间充质干细胞缺乏:对成骨、成软骨和成脂分化的影响。
Int J Mol Sci. 2025 Jul 30;26(15):7363. doi: 10.3390/ijms26157363.
2
Fibroblast growth factor 23 neutralizing antibody partially rescues bone loss and increases hematocrit in sickle cell disease mice.成纤维细胞生长因子23中和抗体可部分挽救镰状细胞病小鼠的骨质流失并提高血细胞比容。
Sci Rep. 2025 Mar 28;15(1):10727. doi: 10.1038/s41598-025-95335-w.
3
"Antenna Effect"-Enhanced AuNPs@rGO Photothermal Coating Promotes 3D Printing of Osteogenic Active Scaffolds to Repair Bone Defects after Malignant Tumor Surgery.
“天线效应”增强的金纳米颗粒@还原氧化石墨烯光热涂层促进成骨活性支架的3D打印以修复恶性肿瘤手术后的骨缺损
Adv Sci (Weinh). 2025 Apr;12(15):e2417346. doi: 10.1002/advs.202417346. Epub 2025 Feb 20.
4
FAM20C: A key protein kinase in multiple diseases.FAM20C:多种疾病中的关键蛋白激酶。
Genes Dis. 2023 Nov 23;12(2):101179. doi: 10.1016/j.gendis.2023.101179. eCollection 2025 Mar.
5
Neural repair function of osteopontin in stroke and stroke‑related diseases (Review).骨桥蛋白在中风及中风相关疾病中的神经修复功能(综述)
Exp Ther Med. 2024 Oct 16;28(6):459. doi: 10.3892/etm.2024.12749. eCollection 2024 Dec.
6
Humanized In Vivo Bone Tissue Engineering: In Vitro Preculture Conditions Control the Structural, Cellular, and Matrix Composition of Humanized Bone Organs.人源化体内骨组织工程:体外预培养条件控制人源化骨器官的结构、细胞和基质组成。
Adv Healthc Mater. 2025 Jan;14(2):e2401939. doi: 10.1002/adhm.202401939. Epub 2024 Oct 23.
7
Osteogenic potentials in canine mesenchymal stem cells: unraveling the efficacy of polycaprolactone/hydroxyapatite scaffolds in veterinary bone regeneration.犬骨髓间充质干细胞的成骨潜能:揭示聚己内酯/羟基磷灰石支架在兽医骨再生中的疗效。
BMC Vet Res. 2024 Sep 9;20(1):403. doi: 10.1186/s12917-024-04246-x.
8
In Vitro Biocompatibility Assessment of Bioengineered PLA-Hydrogel Core-Shell Scaffolds with Mesenchymal Stromal Cells for Bone Regeneration.生物工程化聚乳酸-水凝胶核壳支架与间充质基质细胞用于骨再生的体外生物相容性评估
J Funct Biomater. 2024 Jul 31;15(8):217. doi: 10.3390/jfb15080217.
9
Analysis of the and Splice Variants' Expression Profile under In Vitro Differentiation of Human Mesenchymal Bone Marrow Cells into Osteoblasts.分析人骨髓间充质干细胞体外成骨分化过程中 和 剪接变异体的表达谱。
Cells. 2024 Jun 11;13(12):1021. doi: 10.3390/cells13121021.
10
Novel Biomarkers of Bone Metabolism.新型骨代谢生物标志物。
Nutrients. 2024 Feb 22;16(5):605. doi: 10.3390/nu16050605.